• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB
Click for more information
2.78% 35.0¢

DIMERIX LIMITED - Charts / Financials

Market Cap $192.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing new therapies in areas with unmet medical needs for global markets. It is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. It has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 06/05/2024 (20 minute delay) ?
Day
Open 36.0¢   Day High 37.0¢   Day Low 34.0¢
Daily Volume 5663069
Bids   Sellers
Number Price Volume   Number Price Volume
9 34.5¢ 1445485   1 35.0¢ 24999

Directors & Senior Management

Dr. Nina Webster Chief Executive Officer, Managing Director, Director
Mr. Hamish George Chief Financial Officer, Company Secretary
Dr. David Fuller Chief Medical Officer
Dr. Ash Soman Member of the Executive Board
Mr. Mark Diamond Non-Executive Chairman of the Board
Mr. Hugh Alsop Non-Executive Director
Dr. Sonia Maria Poli Non-Executive Director
Mr. Clinton Snow Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
35.0¢ 		Change
-0.010(2.78%) 		Mkt cap ! $192.3M
Open High Low Value Volume
36.0¢ 37.0¢ 34.0¢ $1.977M 5.663M

Buyers (Bids)

No. Vol. Price($)
9 1445485 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 24999 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
34.5¢ 		  Change
-0.010 ( 4.14 %)
Open High Low Volume
36.5¢ 37.0¢ 34.0¢ 2600347
Last updated 15.59pm 06/05/2024 ?

Top Stories

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy Westpac Banking Corporation has reported a 16 percent drop in net profit (to $3.342 billion) for the first half of the 2024 financial year compared to the same time last year.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.